Search

everythinglearnresearchcommunity

for

Search:↓

Some people with heavy hair shedding might actually have a hidden form of alopecia, which can be identified by specific hair changes.

Epidermal growth factor helps hair recover after chemotherapy.

17-β estradiol and prednisolone may speed up hair regrowth after chemotherapy.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

The combination therapy of PEG-IFN α-2a and Ribavirin can cause widespread hair loss and skin reactions.

A specific gene mutation causes a severe skin disorder in a family.

Pediatric patients with dystrophic epidermolysis bullosa face more hospital admissions, procedures, and complications than others.

Scientists developed a new way to study mutations in a skin condition using blood cells, which may help diagnose and treat the disease.

The document concludes that detailed clinical descriptions of seven family cases help understand dominant dystrophic epidermolysis bullosa's symptoms and inheritance.

17-beta estradiol and prednisolone may help regrow hair damaged by chemotherapy.

The Greek DCQ is a reliable and valid tool for assessing dysmorphic concern.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

People with myotonic dystrophy type 1 have a higher chance of getting skin tumors, including melanoma.

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

A woman with myotonic dystrophy had multiple skin tumors on her scalp, suggesting a genetic link.

HPV does not cause aggressive cancer in RDEB patients.

People with Myotonic Dystrophy type 1 are more likely to have certain skin conditions, but not more likely to get skin cancer.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

A man with myotonic dystrophy type 1 had 28 skin cancers, suggesting a link between the disease and skin cancer, emphasizing the need for sun protection and regular skin checks.

Scientists created a cell model to study and find treatments for a skin disease called RDEB.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Injecting specific cells into the skin can help improve skin structure and reduce blisters in a genetic skin disorder.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

A girl with red hair developed hair-pulling and body image disorders after being bullied for her hair color.

Localized dystrophic epidermolysis bullosa (DEB) can lead to scarring alopecia, highlighting the need to recognize and address this complication.

Scalp hair follicle cells help protect and heal skin in certain skin conditions.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Accurate diagnosis of RDEB-mitis in older adults is crucial for proper management without immunosuppressants.

Scientists created cell lines to study a genetic skin disorder using CRISPR technology.

Most Recessive Dystrophic Epidermolysis Bullosa patients with a specific mutation likely have Sephardic ancestry from about 500 years ago.